FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Shoji Nakamori

Research Profile

Disorders

Chemicals & Drugs

Procedures

Physiology

Gene Expression Regulation, Neoplastic

Anatomy

Concepts & Ideas

Disease-Free Survival

Co-author Network

Publications

TOP 3
Masaru Kubota; Shigeru Marubashi; Morito Monden; Masaki Mori; Takamichi Murakami; Hiroaki Nagano; Shoji Nakamori; Masato Sakon; Masahiro Tanemura; Hiroshi Wada; Keizo Dono; Hidetoshi Eguchi; Shogo Kobayashi; Yuichiro Doki
Xenon-inhalation computed tomography for noninvasive quantitative measurement of tissue blood flow in pancreatic tumor.
Shoji Nakamori; Hiroki Ozato; Takashi Shibata; Yutaka Takeda; Ken Tohno; Yuichirou Doki; Wakio Endo; Yasunori Hasuike; Seizo Masutani; Masaki Mori; Takashi Morimoto; Morito Monden
[Multicenter phase II study of pre-administered uracil/tegafur (UFT) plus gemcitabine for unresectable/recurrent pancreatic cancer].
Yoshiaki Ohmura; Yutaka Takeda; Hiroaki Nagano; Shoji Nakamori; Shogo Kobayashi; Shigeru Marubashi; Hidetoshi Eguchi; Masahiro Tanemura; Toru Kitagawa; Morito Monden; Masaki Mori; Yuichiro Doki
[A case of locally advanced pancreatic cancer with superior membrane artery invasion successfully resected after gemcitabine-based chemoradiotherapy].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Shoji Nakamori (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Masaru Kubota; Shigeru Marubashi; Morito Monden; Masaki Mori; Takamichi Murakami; Hiroaki Nagano; Shoji Nakamori; Masato Sakon; Masahiro Tanemura; Hiroshi Wada; Keizo Dono; Hidetoshi Eguchi; Shogo Kobayashi; Yuichiro Doki
Xenon-inhalation computed tomography for noninvasive quantitative measurement of tissue blood flow in pancreatic tumor.
Digestive diseases and sciences 2012;57(3):801-5.
2011: Shoji Nakamori; Hiroki Ozato; Takashi Shibata; Yutaka Takeda; Ken Tohno; Yuichirou Doki; Wakio Endo; Yasunori Hasuike; Seizo Masutani; Masaki Mori; Takashi Morimoto; Morito Monden
[Multicenter phase II study of pre-administered uracil/tegafur (UFT) plus gemcitabine for unresectable/recurrent pancreatic cancer].
Gan to kagaku ryoho. Cancer & chemotherapy 2011;38(5):789-92.
2009: Yoshiaki Ohmura; Yutaka Takeda; Hiroaki Nagano; Shoji Nakamori; Shogo Kobayashi; Shigeru Marubashi; Hidetoshi Eguchi; Masahiro Tanemura; Toru Kitagawa; Morito Monden; Masaki Mori; Yuichiro Doki
[A case of locally advanced pancreatic cancer with superior membrane artery invasion successfully resected after gemcitabine-based chemoradiotherapy].
Gan to kagaku ryoho. Cancer & chemotherapy 2009;36(12):2428-9.
2009: Hiromitsu Hoshino; Yutaka Takeda; Hiroaki Nagano; Shoji Nakamori; Shogo Kobayashi; Hidetoshi Eguchi; Shigeru Marubashi; Masahiro Tanemura; Toru Kitagawa; Koji Umeshita; Morito Monden; Yuichiro Doki; Masaki Mori
[A long-term survival case of pancreatic cancer with hepatic metastasis after pancreaticoduodenectomy successfully treated by s-1 and gemcitabine combination chemotherapy].
Gan to kagaku ryoho. Cancer & chemotherapy 2009;36(12):2419-21.
2009: H Akita; Z Zheng; Yutaka Takeda; C Kim; N Kittaka; Shogo Kobayashi; Shigeru Marubashi; Ichiro Takemasa; Hiroaki Nagano; Keizo Dono; Shoji Nakamori; Morito Monden; Masatomo Mori; Yuichiro Doki; Gerold Bepler
Significance of RRM1 and ERCC1 expression in resectable pancreatic adenocarcinoma.
Oncogene 2009;28(32):2903-9.
2009: Daisuke Osumi; Motoko Takahashi; Eiji Miyoshi; Shunichi Yokoe; Seung Ho Lee; Katsuhisa Noda; Shoji Nakamori; Jianguo Gu; Yoshitaka Ikeda; Yoshio Kuroki; Kazuo Sengoku; M Ishikawa; Naoyuki Taniguchi
Core fucosylation of E-cadherin enhances cell-cell adhesion in human colon carcinoma WiDr cells.
Cancer science 2009;100(5):888-95.
2009: Yukiyoshi Okauchi; Takao Nammo; Hiromi Iwahashi; Takashi Kizu; Isao Hayashi; Kohei Okita; Kazuya Yamagata; Sae Uno; Fumie Katsube; Munehide Matsuhisa; Ken Kato; Katsuyuki Aozasa; Tonsok Kim; Keigo Osuga; Shoji Nakamori; Yasuhiro Tamaki; Tohru Funahashi; Jun-ichiro Miyagawa; Iichiro Shimomura
Glucagonoma diagnosed by arterial stimulation and venous sampling (ASVS).
Internal medicine (Tokyo, Japan) 2009;48(12):1025-30.
2008: Shin Nakahira; Shoji Nakamori; Masaki Tsujie; Setsuo Takeda; Keishi Sugimoto; Yuji Takahashi; Jiro Okami; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Masato Sakon; Morito Monden
Pretreatment with S-1, an oral derivative of 5-fluorouracil, enhances gemcitabine effects in pancreatic cancer xenografts.
Anticancer research 2008;28(1A):179-86.
2007: Hiroshi Wada; Hiroaki Nagano; Hirofumi Yamamoto; Isao Arai; Hideo Ota; Masato Nakamura; Bazarragchaa Damdinsuren; Takehiro Noda; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Koji Umeshita; Yuichiro Doki; Keizo Dono; Shoji Nakamori; Masato Sakon; Morito Monden
Combination therapy of interferon-alpha and 5-fluorouracil inhibits tumor angiogenesis in human hepatocellular carcinoma cells by regulating vascular endothelial growth factor and angiopoietins.
Oncology reports 2007;18(4):801-9.
2007: Masaki Tsujie; Shoji Nakamori; Shin Nakahira; Yuji Takahashi; Nobuyasu Hayashi; Jiro Okami; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Masato Sakon; Morito Monden
Human equilibrative nucleoside transporter 1, as a predictor of 5-fluorouracil resistance in human pancreatic cancer.
Anticancer research 2007;27(4B):2241-9.
2007: Tameyoshi Yamamoto; Hiroaki Nagano; Yasuharu Imai; Kazuto Fukuda; Hitoshi Matsumoto; Motoi Kondo; Hideo Ota; Masato Nakamura; Hiroshi Wada; Takehiro Noda; Bazarragchaa Damdinsuren; Keizo Dono; Koji Umeshita; Shoji Nakamori; Masato Sakon; Kenichi Wakasa; Morito Monden
Successful treatment of multiple hepatocellular carcinoma with tumor thrombi in the major portal branches by intraarterial 5-fluorouracil perfusion chemotherapy combined with subcutaneous interferon-alpha and hepatectomy.
International journal of clinical oncology 2007;12(2):150-4.
2007: Shin Nakahira; Shoji Nakamori; Masaki Tsujie; Yuji Takahashi; Jiro Okami; Shinichi Yoshioka; Makoto Yamasaki; Shigeru Marubashi; Ichiro Takemasa; Atsushi Miyamoto; Yutaka Takeda; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Masato Sakon; Morito Monden
Involvement of ribonucleotide reductase M1 subunit overexpression in gemcitabine resistance of human pancreatic cancer.
International journal of cancer. Journal international du cancer 2007;120(6):1355-63.
2007: Yubo Yang; Hiroaki Nagano; Hideo Ota; Osakuni Morimoto; Masato Nakamura; Hiroshi Wada; Takehiro Noda; Bazarragchaa Damdinsuren; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Keizo Dono; Koji Umeshita; Shoji Nakamori; Kenichi Wakasa; Masato Sakon; Morito Monden
Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection.
Surgery 2007;141(2):196-202.
2007: Hiroaki Nagano; Masato Sakon; Hidetoshi Eguchi; Motoi Kondo; Tameyoshi Yamamoto; Hideo Ota; Masato Nakamura; Hiroshi Wada; Bazarragchaa Damdinsuren; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Keizo Dono; Koji Umeshit; Shoji Nakamori; Morito Monden
Hepatic resection followed by IFN-alpha and 5-FU for advanced hepatocellular carcinoma with tumor thrombus in the major portal branch.
Hepato-gastroenterology 2007;54(73):172-9.
2007: Isao Arai; Hiroaki Nagano; Motoi Kondo; Hirofumi Yamamoto; Nobuaki Hiraoka; Yurika Sugita; Hideo Ota; Shinichi Yoshioka; Masato Nakamura; Hiroshi Wada; Bazarragchaa Damdinsuren; Hitoshi Kato; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Keizo Dono; Koji Umeshita; Shoji Nakamori; Kenichi Wakasa; Masato Sakon; Morito Monden
Overexpression of MT3-MMP in hepatocellular carcinoma correlates with capsular invasion.
Hepato-gastroenterology 2007;54(73):167-71.
2007: Bazarragchaa Damdinsuren; Hiroaki Nagano; Hiroshi Wada; Motoi Kondo; Hideo Ota; Masato Nakamura; Takehiro Noda; Javzandulam Natsag; Hirofumi Yamamoto; Yuichiro Doki; Koji Umeshita; Keizo Dono; Shoji Nakamori; Masato Sakon; Morito Monden
Stronger growth-inhibitory effect of interferon (IFN)-beta compared to IFN-alpha is mediated by IFN signaling pathway in hepatocellular carcinoma cells.
International journal of oncology 2007;30(1):201-8.
2007: Masato Nakamura; Hiroaki Nagano; Masato Sakon; Tameyoshi Yamamoto; Hideo Ota; Hiroshi Wada; Bazarragchaa Damdinsuren; Takehiro Noda; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Koji Umeshita; Shoji Nakamori; Keizo Dono; Morito Monden
Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro.
Journal of hepatology 2007;46(1):77-88.
2006: Taishi Hata; Masataka Ikeda; Shoji Nakamori; Rei Suzuki; Tonsok Kim; Masayoshi Yasui; Ichiro Takemasa; Masakazu Ikenaga; Hirofumi Yamamoto; Masayuki Ohue; Takamichi Murakami; Mitsugu Sekimoto; Masato Sakon; Morito Monden
Single-photon emission computed tomography in the screening for postoperative pulmonary embolism.
Digestive diseases and sciences 2006;51(11):2073-80.
2006: Hirokazu Uyama; Yasuhiko Tomita; Hideji Nakamura; Shoji Nakamori; Binglin Zhang; Yoshihiko Hoshida; Hirayuki Enomoto; Yorihide Okuda; Masato Sakon; Katsuyuki Aozasa; Ichiro Kawase; Norio Hayashi; Morito Monden
Hepatoma-derived growth factor is a novel prognostic factor for patients with pancreatic cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(20 Pt 1):6043-8.
2006: Masaki Tsujie; Shoji Nakamori; Shin Nakahira; Setsuo Takeda; Yuji Takahashi; Nobuyasu Hayashi; Jiro Okami; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Masato Sakon; Morito Monden
Schedule-dependent therapeutic effects of gemcitabine combined with uracil-tegafur in a human pancreatic cancer xenograft model.
Pancreas 2006;33(2):142-7.
2006: Masaki Tsujie; Shoji Nakamori; Eiichi Tanaka; Hiroaki Nagano; Koji Umeshita; Keizo Dono; Masato Sakon; Takehiro Inoue; Toshihiko Inoue; Morito Monden
Phase I/II trial of hyperfractionated accelerated chemoradiotherapy for unresectable advanced pancreatic cancer.
Japanese journal of clinical oncology 2006;36(8):504-10.
2006: Hideo Ota; Hiroaki Nagano; Yuichiro Doki; Mitsugu Sekimoto; Motoi Kondo; Hiroshi Wada; Masato Nakamura; Takehiro Noda; Bazarragchaa Damdinsuren; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Keizo Dono; Koji Umeshita; Shoji Nakamori; Kenichi Wakasa; Masato Sakon; Morito Monden
Expression of type I interferon receptor as a predictor of clinical response to interferon-alpha therapy of gastrointestinal cancers.
Oncology reports 2006;16(2):249-55.
2006: Hidenori Takahashi; Shoji Nakamori; Shin Nakahira; Masaki Tsujie; Yuji Takahshi; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Masato Sakon; Morito Monden
Surgical outcomes of noninvasive and minimally invasive intraductal papillary-mucinous neoplasms of the pancreas.
Annals of surgical oncology 2006;13(7):955-60.
2006: Hiroshi Wada; Hiroaki Nagano; Hirofumi Yamamoto; Yubo Yang; Motoi Kondo; Hideo Ota; Masato Nakamura; Shinichi Yoshioka; Hitoshi Kato; Bazarragchaa Damdinsuren; Di Tang; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Koji Umeshita; Shoji Nakamori; Masato Sakon; Keizo Dono; Kenichi Wakasa; Morito Monden
Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin-2 and hypoxia-induced factor-1 alpha.
Liver international : official journal of the International Association for the Study of the Liver 2006;26(4):414-23.
2006: Yukinori Kurokawa; Kimi Honma; Ichiro Takemasa; Shoji Nakamori; Hiroko Kita-Matsuo; Masaaki Motoori; Hiroaki Nagano; Keizo Dono; Takahiro Ochiya; Morito Monden; Kikuya Kato
Central genetic alterations common to all HCV-positive, HBV-positive and non-B, non-C hepatocellular carcinoma: a new approach to identify novel tumor markers.
International journal of oncology 2006;28(2):383-91.
2005: Shouho Hayashi; Keizo Dono; Junzo Shimizu; Takamichi Murakami; Manabu Takamura; Tonsok Kim; Masatoshi Hori; Zhenhui Lu; Hiroaki Nagano; Shoji Nakamori; Masato Sakon; Hironobu Nakamura; Morito Monden
New measurement of hepatic blood flow by xenon CT system: an animal study with PGE1.
The Journal of surgical research 2005;129(1):24-30.
2005: Masato Nakamura; Hiroaki Nagano; Masato Sakon; Tameyoshi Yamamoto; Hideo Ota; Hiroshi Wada; Shinichi Yoshioka; Hitoshi Kato; Bazarragchaa Damdinsuren; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Koji Umeshita; Shoji Nakamori; Keizo Dono; Morito Monden
[A case of HCC with inferior caval vein tumor thrombus and multiple pulmonary metastases that remarkably responded to combination therapy of TS-1 and interferon-alpha].
Gan to kagaku ryoho. Cancer & chemotherapy 2005;32(11):1824-8.
2005: Hideo Ota; Hiroaki Nagano; Masato Sakon; Hidetoshi Eguchi; Motoi Kondo; Tameyoshi Yamamoto; Masato Nakamura; Bazarragchaa Damdinsuren; Hiroshi Wada; Shigeru Marubashi; Atsushi Miyamoto; Keizo Dono; Koji Umeshita; Shoji Nakamori; Kenichi Wakasa; Morito Monden
Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-alpha and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expression.
British journal of cancer 2005;93(5):557-64.
2005: Hisashi Abe; Takamichi Murakami; Masaru Kubota; Tonsok Kim; Masatoshi Hori; Masayuki Kudo; Kazuhiko Hashimoto; Shoji Nakamori; Keizo Dono; Kaname Tomoda; Morito Monden; Hironobu Nakamura
Quantitative tissue blood flow evaluation of pancreatic tumor: comparison between xenon CT technique and perfusion CT technique based on deconvolution analysis.
Radiation medicine 2005;23(5):364-70.
2005: Shigeru Marubashi; Keizo Dono; Masato Sakon; Kunihito Gotoh; Hidenori Takahashi; Kazuhiko Hashimoto; Masaru Kubota; Shinji Yamamoto; Atsushi Miyamoto; Hiroaki Nagano; Shoji Nakamori; Koji Umeshita; Morito Monden
Portal venous reconstruction in a living liver donor with an anomalous hepatic arterial and portal venous anatomy.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2005;9(3):365-8.
2005: Motoi Kondo; Hiroaki Nagano; Hiroshi Wada; Bazarragchaa Damdinsuren; Hirofumi Yamamoto; Nobuaki Hiraoka; Hidetoshi Eguchi; Atsushi Miyamoto; Tameyoshi Yamamoto; Hideo Ota; Masato Nakamura; Shigeru Marubashi; Keizo Dono; Koji Umeshita; Shoji Nakamori; Masato Sakon; Morito Monden
Combination of IFN-alpha and 5-fluorouracil induces apoptosis through IFN-alpha/beta receptor in human hepatocellular carcinoma cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(3):1277-86.
2005: Bazarragchaa Damdinsuren; Hiroaki Nagano; Motoi Kondo; Hirofumi Yamamoto; Nobuaki Hiraoka; Tameyoshi Yamamoto; Shigeru Marubashi; Atsushi Miyamoto; Koji Umeshita; Keizo Dono; Shoji Nakamori; Kenichi Wakasa; Masato Sakon; Morito Monden
Expression of Id proteins in human hepatocellular carcinoma: relevance to tumor dedifferentiation.
International journal of oncology 2005;26(2):319-27.
2005: Osakuni Morimoto; Hiroaki Nagano; Atsushi Miyamoto; Yoshiyuki Fujiwara; Motoi Kondo; Tameyoshi Yamamoto; Hideo Ota; Masato Nakamura; Hiroshi Wada; Bazarragchaa Damdinsuren; Shigeru Marubashi; Keizo Dono; Koji Umeshita; Shoji Nakamori; Masato Sakon; Morito Monden
Association between recurrence of hepatocellular carcinoma and alpha-fetoprotein messenger RNA levels in peripheral blood.
Surgery today 2005;35(12):1033-41.
2004: Tameyoshi Yamamoto; Hiroaki Nagano; Masato Sakon; Hiroshi Wada; Hidetoshi Eguchi; Motoi Kondo; Bazarragchaa Damdinsuren; Hideo Ota; Masato Nakamura; Hisashi Wada; Shigeru Marubashi; Atsushi Miyamoto; Keizo Dono; Koji Umeshita; Shoji Nakamori; Hideo Yagita; Morito Monden
Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-alpha/5-fluorouracil against Hepatocellular Carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(23):7884-95.
2004: Shigeru Marubashi; Masato Sakon; Hiroaki Nagano; Kunihito Gotoh; Kazuhiko Hashimoto; Masaru Kubota; Shogo Kobayashi; Shinji Yamamoto; Atsushi Miyamoto; Keizo Dono; Shoji Nakamori; Koji Umeshita; Morito Monden
Effect of portal hemodynamics on liver regeneration studied in a novel portohepatic shunt rat model.
Surgery 2004;136(5):1028-37.
2004: Masato Nakamura; Hiroaki Nagano; Masato Sakon; Motoi Kondo; Tameyoshi Yamamoto; Hideo Ota; Hiroshi Wada; Bazarragchaa Damdinsuren; Yubo Yang; Shigeru Marubashi; Atsushi Miyamoto; Keizo Dono; Koji Umeshita; Shoji Nakamori; Morito Monden
[A case of long-term survivor with multiple pulmonary metastases of HCC after hepatic resection].
Gan to kagaku ryoho. Cancer & chemotherapy 2004;31(11):1939-42.
2004: Hiroshi Wada; Hiroaki Nagano; Keizo Dono; Motoi Kondo; Tameyoshi Yamamoto; Hideo Ota; Masato Nakamura; Shinichi Yoshioka; Bazarragchaa Damdinsuren; Yang Yubo; Shigeru Marubashi; Atsushi Miyamoto; Koji Umeshita; Shoji Nakamori; Masato Sakon; Morito Monden
[Successful treatment for advanced cholangiocellular carcinoma with intrahepatic metastasis and/or portal vein tumor thrombi by intraarterial chemotherapy combined with 5-fluorouracil, adriamycin and cisplatin (FAP)--two cases report].
Gan to kagaku ryoho. Cancer & chemotherapy 2004;31(11):1711-3.
2004: Shigeru Marubashi; Keizo Dono; Hidenori Takahashi; Kazuhiko Hashimoto; Masaru Kubota; Shinji Yamamoto; Atsushi Miyamoto; Hiroaki Nagano; Shoji Nakamori; Koji Umeshita; Masato Sakon; Morito Monden
[A case of successful treatment with combined 5-fluorouracil, adriamycin, cisplatin (FAP) therapy followed by Gemcitabine, UFT therapy and intra-arterial FAP therapy for unresectable advanced gallbladder cancer].
Gan to kagaku ryoho. Cancer & chemotherapy 2004;31(11):1708-10.
2004: Chang De Jin; Tameyoshi Yamamoto; Masato Nakamura; Isao Arai; Rho Kishin; Xu Xing; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Shoji Nakamori; Masato Sakon; Morito Monden
[Influence on 5-fluorouracil metabolism by combination of interferon-alpha and 5-fluorouracil against human hepatocellular carcinoma xenografts].
Gan to kagaku ryoho. Cancer & chemotherapy 2004;31(10):1511-5.
2004: Yukinori Kurokawa; Ryo Matoba; Hiroaki Nagano; Masato Sakon; Ichiro Takemasa; Shoji Nakamori; Keizo Dono; Koji Umeshita; Noriko Ueno; Shin Ishii; Kikuya Kato; Morito Monden
Molecular prediction of response to 5-fluorouracil and interferon-alpha combination chemotherapy in advanced hepatocellular carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(18 Pt 1):6029-38.
2004: T Komori; Ichiro Takemasa; H Higuchi; M Yamasaki; Masataka Ikeda; Hitoshi Yamamoto; Masayuki Ohue; Shoji Nakamori; Mitsugu Sekimoto; K Matsubara; Morito Monden
Identification of differentially expressed genes involved in colorectal carcinogenesis using a cDNA microarray.
Journal of experimental & clinical cancer research : CR 2004;23(3):521-7.
2004: Shinji Yamamoto; Yasuhiko Tomita; Yoshihiko Hoshida; Norishige Iizuka; Shinya Kidogami; Hiroshi Miyata; Shuji Takiguchi; Yoshiyuki Fujiwara; Takushi Yasuda; Masahiko Yano; Shoji Nakamori; Masato Sakon; Morito Monden; Katsuyuki Aozasa
Expression level of valosin-containing protein (p97) is associated with prognosis of esophageal carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(16):5558-65.
2004: Shinji Yamamoto; Yasuhiko Tomita; Yoshihiko Hoshida; Norishige Iizuka; Shigeru Marubashi; Atsushi Miyamoto; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Shoji Nakamori; Masato Sakon; Katsuyuki Aozasa; Morito Monden
Interstitial pneumonia induced by combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma.
Journal of gastroenterology 2004;39(8):793-7.
2004: Yukinori Kurokawa; Ryo Matoba; Ichiro Takemasa; Hiroaki Nagano; Keizo Dono; Shoji Nakamori; Koji Umeshita; Masato Sakon; Noriko Ueno; Shigeyuki Oba; Shin Ishii; Kikuya Kato; Morito Monden
Molecular-based prediction of early recurrence in hepatocellular carcinoma.
Journal of hepatology 2004;41(2):284-91.
2004: Yusuke Oji; Shoji Nakamori; Masahiro Fujikawa; Shin-ichi Nakatsuka; Asumi Yokota; Naoya Tatsumi; Sakie Abeno; Ai Ikeba; Satoshi Takashima; Masaki Tsujie; Hirofumi Yamamoto; Masato Sakon; Riichiro Nezu; Kiyoshi Kawano; Sumiyuki Nishida; Kazuhiro Ikegame; Manabu Kawakami; Akihiro Tsuboi; Yoshihiro Oka; Kiyoshi Yoshikawa; Katsuyuki Aozasa; Morito Monden; Haruo Sugiyama
Overexpression of the Wilms' tumor gene WT1 in pancreatic ductal adenocarcinoma.
Cancer science 2004;95(7):583-7.
2004: Shinji Yamamoto; Yasuhiko Tomita; Yoshihiko Hoshida; Takaya Morooka; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Masato Sakon; Osamu Ishikawa; Hiroaki Ohigashi; Shoji Nakamori; Morito Monden; Katsuyuki Aozasa
Prognostic significance of activated Akt expression in pancreatic ductal adenocarcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(8):2846-50.
2004: Yukinori Kurokawa; Ryo Matoba; Shoji Nakamori; Ichiro Takemasa; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Masato Sakon; Morito Monden; Kikuya Kato
PCR-array gene expression profiling of hepatocellular carcinoma.
Journal of experimental & clinical cancer research : CR 2004;23(1):135-41.
2004: Shogo Kobayashi; Masatoshi Hori; Keizo Dono; Hiroaki Nagano; Koji Umeshita; Shoji Nakamori; Masato Sakon; Keigo Osuga; Keiji Umetani; Takamichi Murakami; Hironobu Nakamura; Morito Monden
In vivo real-time microangiography of the liver in mice using synchrotron radiation.
Journal of hepatology 2004;40(3):405-8.
2004: Minoru Ogawa; Hirofumi Yamamoto; Hiroaki Nagano; Yasuhiro Miyake; Yurika Sugita; Taishi Hata; Byung-No Kim; Chew Yee Ngan; Bazarragchaa Damdinsuren; Masakazu Ikenaga; Masataka Ikeda; Masayuki Ohue; Shoji Nakamori; Mitsugu Sekimoto; Masato Sakon; Nariaki Matsuura; Morito Monden
Hepatic expression of ANG2 RNA in metastatic colorectal cancer.
Hepatology (Baltimore, Md.) 2004;39(2):528-39.
2004: Shinji Yamamoto; Yasuhiko Tomita; Yoshihiko Hoshida; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Masato Sakon; Osamu Ishikawa; Hiroaki Ohigashi; Shoji Nakamori; Morito Monden; Katsuyuki Aozasa
Increased expression of valosin-containing protein (p97) is associated with lymph node metastasis and prognosis of pancreatic ductal adenocarcinoma.
Annals of surgical oncology 2004;11(2):165-72.
2004: Taro Aoki; Atsushi Miyamoto; Shigeru Marubashi; Hiroaki Nagano; Koji Umeshita; Yoshiyuki Fujiwara; Keizo Dono; Shoji Nakamori; Masato Sakon; Morito Monden
Clinical value of alterations in p73 gene, related to p53 at 1p36, in human hepatocellular carcinoma.
International journal of oncology 2004;24(2):441-6.
2004: Shinji Yamamoto; Yasuhiko Tomita; Yoshihiko Hoshida; Masato Sakon; Masao Kameyama; Shingi Imaoka; Mitsugu Sekimoto; Shoji Nakamori; Morito Monden; Katsuyuki Aozasa
Expression of valosin-containing protein in colorectal carcinomas as a predictor for disease recurrence and prognosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(2):651-7.
2004: Shinji Yamamoto; Yasuhiko Tomita; Shoji Nakamori; Yoshihiko Hoshida; Norishige Iizuka; Jiro Okami; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Masato Sakon; Osamu Ishikawa; Hiroaki Ohigashi; Katsuyuki Aozasa; Morito Monden
Valosin-containing protein (p97) and Ki-67 expression is a useful marker in detecting malignant behavior of pancreatic endocrine neoplasms.
Oncology 2004;66(6):468-75.
2004: Masato Sakon; Ajay K Kakkar; Masataka Ikeda; Mitsugu Sekimoto; Shoji Nakamori; Masahiko Yano; Morito Monden
Current status of pulmonary embolism in general surgery in Japan.
Surgery today 2004;34(10):805-10.
2004: Shoji Nakamori; Masanori Tujie; Yuji Takahashi; Shigeru Maruhashi; Atsushi Miyamoto; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Masato Sakon; Morito Monden
[Phase I study of gemcitabine (GEM) and UFT combination chemotherapy for unresectable/recurrent pancreatic cancer].
Gan to kagaku ryoho. Cancer & chemotherapy 2004;31(1):51-4.
2004: Nobuyasu Hayashi; Shoji Nakamori; Nobuaki Hiraoka; Masaki Tsujie; Xu Xundi; Toru Takano; Nobuyuki Amino; Masato Sakon; Morito Monden
Antitumor effects of peroxisome proliferator activate receptor gamma ligands on anaplastic thyroid carcinoma.
International journal of oncology 2004;24(1):89-95.
2004: Xundi Xu; Masato Sakon; Hiroaki Nagano; Nobuaki Hiraoka; Hirofumi Yamamoto; Nobuyasu Hayashi; Keizo Dono; Shoji Nakamori; Koji Umeshita; Yasuhiro Ito; Nariaki Matsuura; Morito Monden
Akt2 expression correlates with prognosis of human hepatocellular carcinoma.
Oncology reports 2004;11(1):25-32.
2004: Nobuyasu Hayashi; Shoji Nakamori; Jiro Okami; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Masato Sakon; Hisashi Narimatsu; Morito Monden
Association between expression levels of CA 19-9 and N-acetylglucosamine-beta;1,3-galactosyltransferase 5 gene in human pancreatic cancer tissue.
Pathobiology : journal of immunopathology, molecular and cellular biology 2004;71(1):26-34.
2004: Shinji Yamamoto; Shoji Nakamori; Masaki Tsujie; Yuji Takahashi; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Masato Sakon; Yasuhiko Tomita; Yoshihiko Hoshida; Katsuyuki Aozasa; Kimitoshi Kohno; Morito Monden
Expression of uridine diphosphate N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyl transferase 3 in adenocarcinoma of the pancreas.
Pathobiology : journal of immunopathology, molecular and cellular biology 2004;71(1):12-8.
2003: Bazarragchaa Damdinsuren; Hiroaki Nagano; Masato Sakon; Motoi Kondo; Tameyoshi Yamamoto; Koji Umeshita; Keizo Dono; Shoji Nakamori; Morito Monden
Interferon-beta is more potent than interferon-alpha in inhibition of human hepatocellular carcinoma cell growth when used alone and in combination with anticancer drugs.
Annals of surgical oncology 2003;10(10):1184-90.
2003: Yukinori Kurokawa; Ryo Matoba; Ichiro Takemasa; Shoji Nakamori; Masaki Tsujie; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Masato Sakon; Noriko Ueno; Hiroko Kita; Shigeyuki Oba; Shin Ishii; Kikuya Kato; Morito Monden
Molecular features of non-B, non-C hepatocellular carcinoma: a PCR-array gene expression profiling study.
Journal of hepatology 2003;39(6):1004-12.
2003: Jiro Okami; Keizo Dono; Masato Sakon; Masaki Tsujie; Nobuyasu Hayashi; Yoshiyuki Fujiwara; Hiroaki Nagano; Koji Umeshita; Shoji Nakamori; Morito Monden
Patterns of regional lymph node involvement in intrahepatic cholangiocarcinoma of the left lobe.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2003;7(7):850-6.
2003: Masato Nakamura; Hiroaki Nagano; Masato Sakon; Tameyoshi Yamamoto; Hideo Ota; Shigeru Marubashi; Atsushi Miyamoto; Keizo Dono; Koji Umeshita; Shoji Nakamori; Naoki Hiramatsu; Norio Hayashi; Morito Monden
[A case of long-term survival with TAE resistant multiple recurrence HCC successfully treated by hepatic resection].
Gan to kagaku ryoho. Cancer & chemotherapy 2003;30(11):1717-21.
2003: Hideo Ota; Hiroaki Nagano; Masato Sakon; Tameyoshi Yamamoto; Masato Nakamura; Shigeru Marubashi; Atsushi Miyamoto; Keizo Dono; Koji Umeshita; Shoji Nakamori; Takamichi Murakami; Hironobu Nakamura; Morito Monden
[A case of successful treatment of advanced hepatocellular carcinoma with tumor thrombi in the major portal branches and inferior vena cava with combined intraarterial 5-fluorouracil, adriamycin and cisplatin therapy].
Gan to kagaku ryoho. Cancer & chemotherapy 2003;30(11):1673-7.
2003: Masaki Tsujie; Shoji Nakamori; Jiro Okami; Nobuyasu Hayashi; Nobuaki Hiraoka; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Masato Sakon; Morito Monden
Thiazolidinediones inhibit growth of gastrointestinal, biliary, and pancreatic adenocarcinoma cells through activation of the peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha pathway.
Experimental cell research 2003;289(1):143-51.
2003: Junzo Shimizu; Hiroshi Oka; Keizo Dono; Masato Sakon; Manabu Takamura; Takamichi Murakami; Shouho Hayashi; Hiroaki Nagano; Shoji Nakamori; Koji Umeshita; Shigeru Sase; Mitsukazu Gotoh; Kenichi Wakasa; Hironobu Nakamura; Morito Monden
Noninvasive quantitative measurement of tissue blood flow in hepatocellular carcinoma using xenon-enhanced computed tomography.
Digestive diseases and sciences 2003;48(8):1510-6.
2003: Hirofumi Yamamoto; Motoi Kondo; Shoji Nakamori; Hiroaki Nagano; Kenichi Wakasa; Yurika Sugita; Jin Chang-De; Shogo Kobayashi; Bazarragchaa Damdinsuren; Keizo Dono; Koji Umeshita; Mitsugu Sekimoto; Masato Sakon; Nariaki Matsuura; Morito Monden
JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis1.
Gastroenterology 2003;125(2):556-71.
2003: Osakuni Morimoto; Hiroaki Nagano; Masato Sakon; Yoshiyuki Fujiwara; Terumasa Yamada; Hidewaki Nakagawa; Atsushi Miyamoto; Motoi Kondo; Isao Arai; Tameyoshi Yamamoto; Hideo Ota; Keizo Dono; Koji Umeshita; Shoji Nakamori; Yo Sasaki; Osamu Ishikawa; Shingi Imaoka; Morito Monden
Diagnosis of intrahepatic metastasis and multicentric carcinogenesis by microsatellite loss of heterozygosity in patients with multiple and recurrent hepatocellular carcinomas.
Journal of hepatology 2003;39(2):215-21.
2003: Masaki Tsujie; Shoji Nakamori; Jiro Okami; Yuji Takahashi; Nobuyasu Hayashi; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Masato Sakon; Morito Monden
Growth inhibition of pancreatic cancer cells through activation of peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha pathway.
International journal of oncology 2003;23(2):325-31.
2003: Shinji Yamamoto; Yasuhiko Tomita; Yoshihiko Hoshida; Shuji Takiguchi; Yoshiyuki Fujiwara; Takushi Yasuda; Masahiko Yano; Shoji Nakamori; Masato Sakon; Morito Monden; Katsuyuki Aozasa
Expression level of valosin-containing protein is strongly associated with progression and prognosis of gastric carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(13):2537-44.
2003: Shogo Kobayashi; Keizo Dono; Shiro Takahara; Yoshitaka Isaka; Enyu Imai; Lu Zhenhui; Hiroaki Nagano; Kato Tomoaki; Koji Umeshita; Shoji Nakamori; Masato Sakon; Morito Monden
Electroporation-mediated ex vivo gene transfer into graft not requiring injection pressure in orthotopic liver transplantation.
The journal of gene medicine 2003;5(6):510-7.
2003: Atsushi Miyamoto; Tomoaki Kato; Keizo Dono; Koji Umeshita; Ryohei Kawabata; Shoho Hayashi; Masaru Kubota; Shogo Kobayashi; Hiroaki Nagano; Shoji Nakamori; Masato Sakon; Morito Monden
Living-related liver transplantation with renoportal anastomosis for a patient with large spontaneous splenorenal collateral.
Transplantation 2003;75(9):1596-8.
2003: Xundi Xu; Hirofumi Yamamoto; Masato Sakon; Masayoshi Yasui; Chew Yee Ngan; Hiroki Fukunaga; Tetsushi Morita; Minoru Ogawa; Hiroaki Nagano; Shoji Nakamori; Mitsugu Sekimoto; Nariaki Matsuura; Morito Monden
Overexpression of CDC25A phosphatase is associated with hypergrowth activity and poor prognosis of human hepatocellular carcinomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(5):1764-72.
2003: Motoi Kondo; Hiroaki Nagano; Masato Sakon; Shouho Hayashi; Jiro Okami; Keizo Dono; Koji Umeshita; Shoji Nakamori; Ken-ichi Wakasa; Morito Monden
The effect of beta-blocker on intractable ascites in cirrhotic patients undergoing hepatectomy for hepatocellular carcinoma.
Hepato-gastroenterology 2003;50(50):504-6.
2003: Shogo Kobayashi; Keizo Dono; Toshiyuki Tanaka; Shiro Takahara; Yoshitaka Isaka; Enyu Imai; Hiroaki Nagano; Kato Tomoaki; Koji Umeshita; Shoji Nakamori; Masato Sakon; Morito Monden
Gene transfer into the liver by plasmid injection into the portal vein combined with electroporation.
The journal of gene medicine 2003;5(3):201-8.
2003: Masaki Tsujie; Shoji Nakamori; Shoichi Nakazuru; Nobuyasu Hayashi; Jiro Okami; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Masato Sakon; Morito Monden
[A case of liver metastasis of pancreatic duct carcinoma successfully treated with gemcitabine].
Gan to kagaku ryoho. Cancer & chemotherapy 2003;30(2):297-301.
2003: Shinji Yamamoto; Yasuhiko Tomita; Shoji Nakamori; Yoshihiko Hoshida; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Masato Sakon; Morito Monden; Katsuyuki Aozasa
Elevated expression of valosin-containing protein (p97) in hepatocellular carcinoma is correlated with increased incidence of tumor recurrence.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(3):447-52.
2003: Naoyoshi Maezaki; Naoto Kojima; Atsunobu Sakamoto; Hiroaki Tominaga; Chuzo Iwata; Tetsuaki Tanaka; Morito Monden; Bazarragchaa Damdinsuren; Shoji Nakamori
Total synthesis of the antitumor acetogenin mosin B: desymmetrization approach to the stereodivergent synthesis of threo/trans/erythro-type acetogenins.
Chemistry (Weinheim an der Bergstrasse, Germany) 2003;9(2):389-99.
2003: Jiro Okami; Shoji Nakamori; Nobuaki Hiraoka; Masaki Tsujie; Nobuyasu Hayashi; Hirofumi Yamamoto; Yoshiyuki Fujiwara; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Masato Sakon; Morito Monden
Suppression of pancreatic cancer cell invasion by a cyclooxygenase-2-specific inhibitor.
Clinical & experimental metastasis 2003;20(7):577-84.
2003: Shizuko Muro; Ichiro Takemasa; Shigeyuki Oba; Ryo Matoba; Noriko Ueno; Chiyuri Maruyama; Riu Yamashita; Mitsugu Sekimoto; Hirofumi Yamamoto; Shoji Nakamori; Morito Monden; Shin Ishii; Kikuya Kato
Identification of expressed genes linked to malignancy of human colorectal carcinoma by parametric clustering of quantitative expression data.
Genome biology 2003;4(3):R21.
2002: Jiro Okami; Shoji Nakamori; Hitoshi Yamamoto; Masato Sakon; Masaki Tsujie; N Hayashi; Hiroaki Nagano; Keizo Dono; Koji Umeshita; O Ishikawa; H Ohigashi; Morito Monden
An immunohistochemical study of cyclooxygenase (COX)-2 expression in endocrine tumors of the pancreas.
Journal of experimental & clinical cancer research : CR 2002;21(4):569-76.
2002: Tameyoshi Yamamoto; Hiroaki Nagano; Masato Sakon; Takushi Yasuda; Hiroyoshi Takemoto; Tadashi Tsujino; Hideo Ota; Keizo Dono; Koji Umeshita; Shoji Nakamori; Masahiko Yano; Keigo Osuga; Takamichi Murakami; Hironobu Nakamura; Morito Monden
[A case of postoperative multiple hepatic metastasis from gastric cancer successfully treated by percutaneous microwave coagulation therapy and hepatic arterial infusion chemotherapy].
Gan to kagaku ryoho. Cancer & chemotherapy 2002;29(12):2429-32.
2002: Hideo Ota; Hiroaki Nagano; Masato Sakon; Tsuyoshi Inoue; Shoho Hayashi; Motoi Kondo; Isao Arai; Osakuni Morimoto; Tameyoshi Yamamoto; Masato Nakamura; Keizo Dono; Koji Umeshita; Shoji Nakamori; Kenichi Wakasa; Morito Monden
[Hepatocellular carcinoma recurrence in PEI site--a case report].
Gan to kagaku ryoho. Cancer & chemotherapy 2002;29(12):2421-4.
2002: Motoi Kondo; Keizo Dono; Masato Sakon; Junzo Shimizu; Hiroaki Nagano; Shoji Nakamori; Koji Umeshita; Ken-ichi Wakasa; Morito Monden
Adenosquamous carcinoma of the gallbladder.
Hepato-gastroenterology 2002;49(47):1230-4.
2002: Yoshihisa Tsuji; Shoji Nakamori; Hideo Ariyoshi; Masato Sakon; Yasuhisa Aono; Atsushi Ueda; Masaru Tokunaga; Takashi Nakamura; Morito Monden
Cancer cell contact causes oscillatory and polarized rise of cytoplasmic ionized calcium concentration in human umbilical vein endothelial cells.
International journal of oncology 2002;21(3):541-6.
2002: Toru Takano; Yukiko Hasegawa; Akira Miyauchi; Fumio Matsuzuka; Hiroshi Yoshida; Kanji Kuma; Nobuyasu Hayashi; Shoji Nakamori; Nobuyuki Amino
Quantitative analysis of osteonectin mRNA in thyroid carcinomas.
Endocrine journal 2002;49(4):511-6.
2002: Masato Sakon; Hiroaki Nagano; Keizo Dono; Shoji Nakamori; Koji Umeshita; Akira Yamada; Sumio Kawata; Yasuharu Imai; Shohei Iijima; Morito Monden
Combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches.
Cancer 2002;94(2):435-42.
2002: Hidetoshi Eguchi; Hiroaki Nagano; Masato Sakon; Atsushi Miyamoto; Motoi Kondo; Isao Arai; Osakuni Morimoto; Keizo Dono; Koji Umeshita; Shoji Nakamori; Kenichi Wakasa; Morito Monden
A successful resection and long-term survival of a patient with intrahepatic recurrences of combined hepatocellular-cholangiocarcinoma: report of a case.
Surgery today 2002;32(8):742-6.
2002: Osakuni Morimoto; Hiroaki Nagano; Masato Sakon; Hidetoshi Eguchi; Atsushi Miyamoto; Motoi Kondo; Isao Arai; Tameyoshi Yamamoto; Keizo Dono; Koji Umeshita; Manabu Takamura; Takamichi Murakami; Shoji Nakamori; Hironobu Nakamura; Morito Monden
Liver abscess formation after microwave coagulation therapy applied for hepatic metastases from surgically excised bile duct cancer: report of a case.
Surgery today 2002;32(5):454-7.
2002: Masato Sakon; Hiroaki Nagano; Shoji Nakamori; Keizo Dono; Koji Umeshita; Takamichi Murakami; Hironobu Nakamura; Morito Monden
Intrahepatic recurrences of hepatocellular carcinoma after hepatectomy: analysis based on tumor hemodynamics.
Archives of surgery (Chicago, Ill. : 1960) 2002;137(1):94-9.
2001: Tameyoshi Yamamoto; Hiroaki Nagano; Masato Sakon; Atsushi Miyamoto; Motoi Kondo; Isao Arai; Osakuni Morimoto; Keizo Dono; Koji Umeshita; Shoji Nakamori; Takamichi Murakami; Hideji Nakamura; Morito Monden
[A patient with hepatocellular carcinoma and portal vein thrombosis in 1st branch who was treated by transcatheter arterial embolization].
Gan to kagaku ryoho. Cancer & chemotherapy 2001;28(11):1718-23.
2001: Hiroaki Nagano; Masato Sakon; Takushi Yasuda; Keizo Dono; Shoji Nakamori; Masahiko Yano; Koji Umeshita; Hitoshi Shiozaki; Akira Okada; Takamichi Murakami; Hideji Nakamura; Morito Monden
[A case of postoperative multiple hepatic metastasis from esophageal cancer successfully treated by surgical resection and hepatic arterial infusion chemotherapy].
Gan to kagaku ryoho. Cancer & chemotherapy 2001;28(11):1628-31.
2001: Norio Hayashi; Hitoshi Yamamoto; Nobuaki Hiraoka; Keizo Dono; Yasuhiro Ito; Jiro Okami; Motoi Kondo; Hiroaki Nagano; Koji Umeshita; Masato Sakon; Nariaki Matsuura; Shoji Nakamori; Morito Monden
Differential expression of cyclooxygenase-2 (COX-2) in human bile duct epithelial cells and bile duct neoplasm.
Hepatology (Baltimore, Md.) 2001;34(4 Pt 1):638-50.
2001: K Shiozaki; Shoji Nakamori; Masaki Tsujie; Jiro Okami; Hitoshi Yamamoto; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Masato Sakon; H Furukawa; M Hiratsuka; T Kasugai; S Ishiguro; Morito Monden
Human stomach-specific gene, CA11, is down-regulated in gastric cancer.
International journal of oncology 2001;19(4):701-7.
2001: Ichiro Takemasa; Haruhisa Higuchi; Hirofumi Yamamoto; M Sekimoto; Naruya Tomita; Shoji Nakamori; Ryo Matoba; Morito Monden; K Matsubara
Construction of preferential cDNA microarray specialized for human colorectal carcinoma: molecular sketch of colorectal cancer.
Biochemical and biophysical research communications 2001;285(5):1244-9.
2001: Hitoshi Yamamoto; Yasuhiro Miyake; Shingo Noura; Tadashi Ohnishi; Osamu Takayama; Masakazu Ikenaga; Yoshiyuki Fujiwara; Shoji Nakamori; Mitsugu Sekimoto; Morito Monden
[Clinical significance of micrometastasis to lymph nodes in gastrointestinal tract cancers].
Gan to kagaku ryoho. Cancer & chemotherapy 2001;28(6):776-83.
2001: Atsushi Miyamoto; Hiroaki Nagano; Masato Sakon; Yoshiyuki Fujiwara; Yurika Sugita; Hidetoshi Eguchi; Motoi Kondo; Isao Arai; Osakuni Morimoto; Keizo Dono; Koji Umeshita; Shoji Nakamori; Morito Monden
Clinical application of quantitative analysis for detection of hematogenous spread of hepatocellular carcinoma by real-time PCR.
International journal of oncology 2001;18(3):527-32.
2001: M Wang; Masato Sakon; Koji Umeshita; M Okuyama; K Shiozaki; Hiroaki Nagano; K Dohno; Shoji Nakamori; Morito Monden
Prednisolone suppresses ischemia-reperfusion injury of the rat liver by reducing cytokine production and calpain mu activation.
Journal of hepatology 2001;34(2):278-83.
2001: Masato Sakon; Yasuhisa Aono; Hideo Ariyoshi; Atsushi Ueda; Yoshihisa Tsuji; Koji Umeshita; Hiroaki Nagano; Keizo Dono; Shoji Nakamori; Morito Monden
Involvement of calcium influx in hypoxia-induced bleb formation in human umbilical vein endothelial cells.
Transplantation proceedings 2001;33(1-2):898.
2000: Atsushi Miyamoto; Koji Umeshita; Masato Sakon; Hiroaki Nagano; Hiroshi Eguchi; S Kishimoto; Keizo Dono; Shoji Nakamori; M Gotoh; Morito Monden
Advanced hepatocellular carcinoma with distant metastases, successfully treated by a combination therapy of alpha-interferon and oral tegafur/uracil.
Journal of gastroenterology and hepatology 2000;15(12):1447-51.
2000: Masato Sakon; Koji Umeshita; Hiroaki Nagano; H Eguchi; S Kishimoto; Atsushi Miyamoto; S Ohshima; Keizo Dono; Shoji Nakamori; M Gotoh; Morito Monden
Clinical significance of hepatic resection in hepatocellular carcinoma: analysis by disease-free survival curves.
Archives of surgery (Chicago, Ill. : 1960) 2000;135(12):1456-9.
2000: Hidetoshi Eguchi; Koji Umeshita; Masato Sakon; Hiroaki Nagano; Yasuhiro Ito; S I Kishimoto; Keizo Dono; Shoji Nakamori; Tsutomu Takeda; Mitsukazu Gotoh; Kenichi Wakasa; Nariaki Matsuura; Morito Monden
Presence of active hepatitis associated with liver cirrhosis is a risk factor for mortality caused by posthepatectomy liver failure.
Digestive diseases and sciences 2000;45(7):1383-8.
2000: Atsushi Miyamoto; Y Fujiwara; Masato Sakon; Hiroaki Nagano; Y Sugita; M Kondo; Hidetoshi Eguchi; Keizo Dono; Koji Umeshita; Shoji Nakamori; Morito Monden
Development of a multiple-marker RT-PCR assay for detection of micrometastases of hepatocellular carcinoma.
Digestive diseases and sciences 2000;45(7):1376-82.
2000: Hidetoshi Eguchi; Hiroaki Nagano; Hitoshi Yamamoto; Atsushi Miyamoto; Motoi Kondo; Keizo Dono; Shoji Nakamori; Koji Umeshita; Masato Sakon; Morito Monden
Augmentation of antitumor activity of 5-fluorouracil by interferon alpha is associated with up-regulation of p27Kip1 in human hepatocellular carcinoma cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(7):2881-90.
2000: Motoi Kondo; Hiroaki Nagano; Masato Sakon; Hitoshi Yamamoto; Osakuni Morimoto; Isao Arai; Atsushi Miyamoto; Hidetoshi Eguchi; Keizo Dono; Shoji Nakamori; Koji Umeshita; Kenichi Wakasa; Y Ohmoto; Morito Monden
Expression of interferon alpha/beta receptor in human hepatocellular carcinoma.
International journal of oncology 2000;17(1):83-8.
2000: S Kishimoto; Masato Sakon; Koji Umeshita; Hideyuki Miyoshi; Kazunori Taniguchi; W Meng; Hiroaki Nagano; Keizo Dono; H Ariyosi; Shoji Nakamori; Tomio Kawasaki; M Gotoh; Morito Monden; S Imajoh-Ohmi
The inhibitory effect of prostaglandin E1 on oxidative stress-induced hepatocyte injury evaluated by calpain-mu activation.
Transplantation 2000;69(11):2314-9.
2000: Jiro Okami; K Dohno; Masato Sakon; Kyoko Iwao; Terumasa Yamada; Hitoshi Yamamoto; Yoshiyuki Fujiwara; Hiroaki Nagano; Koji Umeshita; Nariaki Matsuura; Shoji Nakamori; Morito Monden
Genetic detection for micrometastasis in lymph node of biliary tract carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(6):2326-32.
2000: Terumasa Yamada; Shoji Nakamori; Hiroki Ohzato; Naozumi Higaki; Taro Aoki; S Oshima; K Shiozaki; Jiro Okami; Nobuyasu Hayashi; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Masato Sakon; Morito Monden
Outcome of pancreatic cancer patients based on genetic lymph node staging.
International journal of oncology 2000;16(6):1165-71.
2000: Yoshiyuki Fujiwara; Yurika Sugita; Shoji Nakamori; Atsushi Miyamoto; K Shiozaki; Hiroaki Nagano; Masato Sakon; Morito Monden
Assessment of Stanniocalcin-1 mRNA as a molecular marker for micrometastases of various human cancers.
International journal of oncology 2000;16(4):799-804.
2000: Y Ito; Morito Monden; T Takeda; Hidetoshi Eguchi; Koji Umeshita; Hiroaki Nagano; Shoji Nakamori; Keizo Dono; Masato Sakon; Masato Nakamura; M Tsujimoto; M Nakahara; K Nakao; Y Yokosaki; Nariaki Matsuura
The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma.
British journal of cancer 2000;82(6):1211-7.
1999: K Gotoh; Hiroaki Nagano; Masato Sakon; Atsushi Miyamoto; J Shimizu; H Taniguchi; Keizo Dono; Shoji Nakamori; Koji Umeshita; M Gotoh; Hideji Nakamura; Kenichi Wakasa; Morito Monden
[A case of mucinous cholangiocarcinoma with lymph node metastasis].
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 1999;96(12):1401-6.
1999: Motoi Kondo; Hitoshi Yamamoto; Hiroaki Nagano; Jiro Okami; Y Ito; J Shimizu; Hidetoshi Eguchi; Atsushi Miyamoto; Keizo Dono; Koji Umeshita; Nariaki Matsuura; Ken-ichi Wakasa; Shoji Nakamori; Masato Sakon; Morito Monden
Increased expression of COX-2 in nontumor liver tissue is associated with shorter disease-free survival in patients with hepatocellular carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(12):4005-12.
1999: Taro Aoki; Masato Sakon; Hiroki Ohzato; S Kishimoto; S Oshima; Terumasa Yamada; Naozumi Higaki; Shoji Nakamori; M Gotoh; O Ishikawa; H Ohigashi; Shingi Imaoka; Yasunori Hasuike; K Shibata; Morito Monden
Evaluation of preoperative and intraoperative arterial stimulation and venous sampling for diagnosis and surgical resection of insulinoma.
Surgery 1999;126(5):968-73.
1999: Y Ito; Nariaki Matsuura; Masato Sakon; T Takeda; Koji Umeshita; Hiroaki Nagano; Shoji Nakamori; Keizo Dono; M Tsujimoto; M Nakahara; K Nakao; Morito Monden
Both cell proliferation and apoptosis significantly predict shortened disease-free survival in hepatocellular carcinoma.
British journal of cancer 1999;81(4):747-51.
1999: Junzo Shimizu; Hiroaki Nagano; Masato Sakon; Keizo Dono; Yutaka Takeda; S Kishimoto; Hidetoshi Eguchi; Atsushi Miyamoto; Motoi Kondo; Shoji Nakamori; Koji Umeshita; Hideji Nakamura; Kenichi Wakasa; Morito Monden
[A case report of hepatocellular carcinoma with hepatic and portal venous tumor thrombus and multiple intrahepatic metastasis who survived over 1 year after the operation with combined locoregional chemotherapy].
Gan to kagaku ryoho. Cancer & chemotherapy 1999;26(12):1895-9.
1999: Shoji Nakamori; S Nishihara; Y Ikehara; Hiroaki Nagano; Keizo Dono; Masato Sakon; Hisashi Narimatsu; Morito Monden
Molecular mechanism involved in increased expression of sialyl Lewis antigens in ductal carcinoma of the pancreas.
Journal of experimental & clinical cancer research : CR 1999;18(3):425-32.
1999: Jiro Okami; Hitoshi Yamamoto; Yoshiyuki Fujiwara; Masaki Tsujie; Motoi Kondo; Shingo Noura; S Oshima; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Osamu Ishikawa; Masato Sakon; Nariaki Matsuura; Shoji Nakamori; Morito Monden
Overexpression of cyclooxygenase-2 in carcinoma of the pancreas.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(8):2018-24.
1999: Junzo Shimizu; Keizo Dono; Mitsukazu Gotoh; Y Hasuike; Tonsok Kim; Takamichi Murakami; Masato Sakon; Koji Umeshita; Hiroaki Nagano; Shoji Nakamori; N Kato; T Miyazawa; Hironobu Nakamura; Morito Monden
Evaluation of regional liver function by gadolinium-EOB-DTPA-enhanced MR imaging.
Digestive diseases and sciences 1999;44(7):1330-7.
1999: Yasuhiro Ito; Nariaki Matsuura; Masato Sakon; Eiji Miyoshi; Katsuhisa Noda; Tsutomu Takeda; Koji Umeshita; Hiroaki Nagano; Shoji Nakamori; Keizo Dono; Masahiko Tsujimoto; M Nakahara; Kazuwa Nakao; Naoyuki Taniguchi; Morito Monden
Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
Hepatology (Baltimore, Md.) 1999;30(1):90-9.
1999: T Grtochowiecki; M Gotoh; Keizo Dono; Yutaka Takeda; M Nishihara; Y Ohta; H Ota; Hiroki Ohzato; M Okuyama; J Shimizu; F Kimura; L He; Hiroaki Nagano; Shoji Nakamori; Koji Umeshita; Masato Sakon; Morito Monden
Pretreatment of crude pancreatic islets with mitomycin C prolongs graft survival time in xenogeneic rat-to-mouse model.
Transplantation 1999;67(11):1474-7.
1999: Koji Umeshita; M Gotoh; J Shimizu; Yutaka Takeda; Hiroaki Nagano; Keizo Dono; Shoji Nakamori; Masato Sakon; J Okamura; Morito Monden
Evaluation of patient selection criteria for liver transplantation: eight-year experience.
Transplantation proceedings 1999;31(1-2):376-7.
1999: H Ota; M Gotoh; Hiroki Ohzato; L He; T Tanigawa; Hiroaki Nagano; Keizo Dono; Yutaka Takeda; M Okuyama; J Shimizu; Koji Umeshita; Shoji Nakamori; Masato Sakon; Isamu Nishisho; Morito Monden
Microchimerism in thymus is associated with up-regulated T helper type 1 cytokine transcription during cardiac allograft rejection in rats.
Transplantation 1999;67(1):165-73.
1998: Terumasa Yamada; Shoji Nakamori; Hiroki Ohzato; S Oshima; Taro Aoki; Naozumi Higaki; K Sugimoto; K Akagi; Yoshiyuki Fujiwara; Isamu Nishisho; Masato Sakon; M Gotoh; Morito Monden
Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(6):1527-32.
1997: Shoji Nakamori; M Kameyama; H Furukawa; O Takeda; S Sugai; Shingi Imaoka; Y Nakamura
Genetic detection of colorectal cancer cells in circulation and lymph nodes.
Diseases of the colon and rectum 1997;40(10 Suppl):S29-36.